Literature DB >> 16416179

Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice.

Raffaella Scagliarini1, Elena Magnani, Antonino Praticò, Renato Bocchini, Paola Sambo, Paolo Pazzi.   

Abstract

Acid-suppressive therapy (AST) is largely prescribed in both hospital and general practice setting but few data are available on appropriateness of AST use in hospitalized patients and its fallout on prescribing in general practice. We assessed AST in patients consecutively admitted to an internal medicine department to determine the type and timing of prescription and indication for use according to widely accepted guidelines. Prescriptions were rated as indicated, acceptable, or not indicated. Overall, 58.7% of 834 admitted patients received AST, mainly proton pump inhibitors. The prescriptions were indicated in 50.1% of patients, not indicated in 41.5%, and acceptable in 6.5%. The main reason for inappropriate use was prophylaxis in low-risk patients (64.8%). On admission, 35.7% of 112 patients already on AST were judged to receive inappropriate prescription; of 348 patients discharged on AST, overuse was identified in 38.5%. No significant difference was observed for inappropriate use at admission, during hospitalization, and at discharge. In 64 inpatients (7.7%) AST, although indicated, mainly for ulcer prophylaxis in high-risk patients, was not prescribed. In conclusion, AST is substantially over-used in both hospital and general practice settings, mainly for ulcer prophylaxis in low-risk patients. On the other hand, AST is underused in a small, but not negligible proportion of high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16416179     DOI: 10.1007/s10620-005-3052-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

Review 1.  Nonassociation of adrenocorticosteroid therapy and peptic ulcer.

Authors:  H O Conn; B L Blitzer
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

2.  Are we correctly using the inhibitors of gastric acid secretion and cytoprotective drugs? Results of a multicentre study.

Authors:  R Gullotta; L Ferraris; C Cortelezzi; G Minoli; A Prada; U Comin; F Rocca; A Ferrara; M Curzio
Journal:  Ital J Gastroenterol Hepatol       Date:  1997-08

3.  Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.

Authors:  N Hudson; A S Taha; R I Russell; P Trye; J Cottrell; S G Mann; A J Swanell; R D Sturrock; C J Hawkey
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

Review 4.  Epidemiology of NSAID-related gastroduodenal mucosal injury.

Authors:  C Aalykke; K Lauritsen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2001-10       Impact factor: 3.043

5.  A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

Authors:  N D Yeomans; Z Tulassay; L Juhász; I Rácz; J M Howard; C J van Rensburg; A J Swannell; C J Hawkey
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

6.  Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

Authors:  J Y Lau; J J Sung; K K Lee; M Y Yung; S K Wong; J C Wu; F K Chan; E K Ng; J H You; C W Lee; A C Chan; S C Chung
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

7.  Long term acid suppressing treatment in general practice.

Authors:  S D Ryder; S O'Reilly; R J Miller; J Ross; M R Jacyna; A J Levi
Journal:  BMJ       Date:  1994-03-26

8.  Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases.

Authors:  A Niklasson; A Bajor; L Bergendal; M Simrén; H Strid; E Björnsson
Journal:  Respir Med       Date:  2003-10       Impact factor: 3.415

Review 9.  Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.

Authors:  A H Soll
Journal:  JAMA       Date:  1996-02-28       Impact factor: 56.272

10.  Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.

Authors:  A S Taha; N Hudson; C J Hawkey; A J Swannell; P N Trye; J Cottrell; S G Mann; T J Simon; R D Sturrock; R I Russell
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

View more
  12 in total

1.  Overprescribing PPIs: Time for a hospital antacid policy on Clostridium difficile.

Authors:  Jecko Thachil
Journal:  BMJ       Date:  2008-01-19

2.  Imprudent Gastro-protective Approach in Majority of Specialists' Clinics of a Tertiary Hospital.

Authors:  Hardik Rameshbhai Patel; Priti Dhande
Journal:  J Clin Diagn Res       Date:  2016-03-01

3.  Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers?

Authors:  Abeer Zeitoun; Maya Zeineddine; Hani Dimassi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2011-08-06

Review 4.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

5.  Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding.

Authors:  Shoshana J Herzig; Byron P Vaughn; Michael D Howell; Long H Ngo; Edward R Marcantonio
Journal:  Arch Intern Med       Date:  2011-02-14

6.  Improving appropriateness of acid-suppressive medication use via computerized clinical decision support.

Authors:  Shoshana J Herzig; Jamey R Guess; David B Feinbloom; May Adra; Kevin A Afonso; Michael D Howell; Edward R Marcantonio
Journal:  J Hosp Med       Date:  2015-01       Impact factor: 2.960

7.  Inappropriate use of proton pump inhibitors in a local setting.

Authors:  Christopher Tze Wei Chia; Wan Peng Lim; Charles Kien Fong Vu
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858

8.  Appropriateness of treatment recommendations for PPI in hospital discharge letters.

Authors:  Dirk Ahrens; Jean-François Chenot; Gesa Behrens; Thomas Grimmsmann; Michael M Kochen
Journal:  Eur J Clin Pharmacol       Date:  2010-08-06       Impact factor: 2.953

9.  Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge.

Authors:  Verónica Gamelas; Vera Salvado; Luís Dias
Journal:  GE Port J Gastroenterol       Date:  2018-05-02

Review 10.  Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.

Authors:  Imad M Tleyjeh; Aref A Bin Abdulhak; Muhammad Riaz; Faisal A Alasmari; Musa A Garbati; Mushabab AlGhamdi; Abdur Rahman Khan; Mohamad Al Tannir; Patricia J Erwin; Talal Ibrahim; Abed Allehibi; Larry M Baddour; Alex J Sutton
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.